104 related articles for article (PubMed ID: 8375791)
1. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study].
Leuchtgens H
Fortschr Med; 1993 Jul; 111(20-21):352-4. PubMed ID: 8375791
[TBL] [Abstract][Full Text] [Related]
2. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J
Fortschr Med; 1996 Aug; 114(24):291-6. PubMed ID: 8974970
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
Zapfe jun G
Phytomedicine; 2001 Jul; 8(4):262-6. PubMed ID: 11515715
[TBL] [Abstract][Full Text] [Related]
4. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
Degenring FH; Suter A; Weber M; Saller R
Phytomedicine; 2003; 10(5):363-9. PubMed ID: 12833999
[TBL] [Abstract][Full Text] [Related]
5. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
[TBL] [Abstract][Full Text] [Related]
6. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure.
Tauchert M
Am Heart J; 2002 May; 143(5):910-5. PubMed ID: 12040357
[TBL] [Abstract][Full Text] [Related]
9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M
Phytomedicine; 2011 Nov; 18(14):1214-9. PubMed ID: 21784624
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of Korodin Herz-Kreislauf-Tropfen as add-on treatment in older patients with orthostatic hypotension.
Kroll M; Ring C; Gaus W; Hempel B
Phytomedicine; 2005 Jun; 12(6-7):395-402. PubMed ID: 16008114
[TBL] [Abstract][Full Text] [Related]
11. Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M
Eur J Heart Fail; 2000 Dec; 2(4):431-7. PubMed ID: 11113721
[TBL] [Abstract][Full Text] [Related]
12. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
Assmann I; Kassel P; Duck HG; Fiehring H; Morgan P; Schmidt PK; Höfs T; Nehmiz G
Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
[TBL] [Abstract][Full Text] [Related]
13. [Perindopril and chronic heart failure].
Bounhoure JP
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
[TBL] [Abstract][Full Text] [Related]
14. Camphor-Crataegus berry extract combination dose-dependently reduces tilt induced fall in blood pressure in orthostatic hypotension.
Belz GG; Butzer R; Gaus W; Loew D
Phytomedicine; 2002 Oct; 9(7):581-8. PubMed ID: 12487321
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of the changes produced by nitrates in patients with chronic heart insufficiency].
Almenar L; Gimeno JV; Sotillo J; Moreno MT; Salvador A; Miró V; Mora V; Martínez Dolz L; Algarra F
Rev Esp Cardiol; 1993 May; 46(5):298-303. PubMed ID: 8516538
[TBL] [Abstract][Full Text] [Related]
16. Enalapril in chronic heart failure, a double-blind placebo-controlled study.
Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K
Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study.
Asgary S; Naderi GH; Sadeghi M; Kelishadi R; Amiri M
Drugs Exp Clin Res; 2004; 30(5-6):221-5. PubMed ID: 15700749
[TBL] [Abstract][Full Text] [Related]
18. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review.
Holubarsch CJF; Colucci WS; Eha J
Am J Cardiovasc Drugs; 2018 Feb; 18(1):25-36. PubMed ID: 29080984
[TBL] [Abstract][Full Text] [Related]
19. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
20. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure].
Tauchert M; Gildor A; Lipinski J
Herz; 1999 Oct; 24(6):465-74; discussion 475. PubMed ID: 10546150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
